[go: up one dir, main page]

SE0101220D0 - New use - Google Patents

New use

Info

Publication number
SE0101220D0
SE0101220D0 SE0101220A SE0101220A SE0101220D0 SE 0101220 D0 SE0101220 D0 SE 0101220D0 SE 0101220 A SE0101220 A SE 0101220A SE 0101220 A SE0101220 A SE 0101220A SE 0101220 D0 SE0101220 D0 SE 0101220D0
Authority
SE
Sweden
Prior art keywords
new use
glycoconjugates
colon
glucocorticosteroids
ibs
Prior art date
Application number
SE0101220A
Other languages
English (en)
Inventor
Ralph Brattsand
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0101220A priority Critical patent/SE0101220D0/sv
Publication of SE0101220D0 publication Critical patent/SE0101220D0/sv
Priority to PCT/SE2002/000662 priority patent/WO2002080931A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/549Sugars, nucleosides, nucleotides or nucleic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE0101220A 2001-04-04 2001-04-04 New use SE0101220D0 (sv)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SE0101220A SE0101220D0 (sv) 2001-04-04 2001-04-04 New use
PCT/SE2002/000662 WO2002080931A1 (en) 2001-04-04 2002-04-02 New use of glyconjugates of glucocorticosteroids as a targeting to the colon

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0101220A SE0101220D0 (sv) 2001-04-04 2001-04-04 New use

Publications (1)

Publication Number Publication Date
SE0101220D0 true SE0101220D0 (sv) 2001-04-04

Family

ID=20283686

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0101220A SE0101220D0 (sv) 2001-04-04 2001-04-04 New use

Country Status (2)

Country Link
SE (1) SE0101220D0 (sv)
WO (1) WO2002080931A1 (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY199937A (en) 2016-11-08 2023-11-29 Regeneron Pharma Steroids and protein-conjugates thereof
KR20200007905A (ko) 2017-05-18 2020-01-22 리제너론 파마슈티칼스 인코포레이티드 사이클로덱스트린 단백질 약물 접합체
CN111601619A (zh) 2017-11-07 2020-08-28 里珍纳龙药品有限公司 用于抗体药物偶联物的亲水性连接体
US12070506B2 (en) 2018-01-08 2024-08-27 Regeneron Pharmaceuticals, Inc. Steroids and antibody-conjugates thereof
AU2019265703A1 (en) 2018-05-09 2020-11-19 Regeneron Pharmaceuticals, Inc. Anti-MSR1 antibodies and methods of use thereof
TW202304464A (zh) * 2021-03-23 2023-02-01 美商美國禮來大藥廠 新穎糖皮質素受體激動劑

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0678097T3 (da) * 1993-01-08 2000-02-07 Astra Ab Hidtil ukendte colon- eller ileumspecifikke steroidderivater

Also Published As

Publication number Publication date
WO2002080931A1 (en) 2002-10-17

Similar Documents

Publication Publication Date Title
SE0301700D0 (sv) Novel compounds
BR0207640A (pt) Composição farmacêutica oral de cefpodoxima proxetil
SE0301653D0 (sv) Novel compounds
NO20070224L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
BRPI0417717A (pt) composto, composição farmacêutica, e, uso de um composto
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
BR9917007A (pt) Moduladores de ccr5
IS6658A (is) Ný efnasambönd
DE60225040D1 (de) Montelukast-granulatformulierung
TR200200768T2 (tr) Yeni kuinüklidin türevleri ve bunu içeren ilaç bileşimleri
SE0001899D0 (sv) New compounds
SE0101675D0 (sv) Novel composition
EA200401526A1 (ru) Новые соединения и их применение
CY1111567T1 (el) Ενδιαμεσα διβενζο (b,f) αζεπινης
UY27852A1 (es) Difenilazatidinonas cationicamente sustituidas, procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso.
EP1423137A4 (en) Lipopeptide stereoisomers, methods for preparing same, and useful intermediates
SE9901077D0 (sv) Novel use
NO20043016L (no) 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav
SE0102716D0 (sv) Novel compounds
SE9804212D0 (sv) Compounds
SE9801494D0 (sv) Novel use
MXPA05008960A (es) Oxazolidinonas de indolona antibacteriales, intermedios para su preparacion y composiciones farmaceuticas que las contienen.
EA200300727A1 (ru) Производные 2h-1-бензопирана, способы их получения и их фармацевтические композиции
SE0101220D0 (sv) New use
EE200200252A (et) Antikehade kasutamine vaktsiinidena, antikehi sisaldavad farmatseutilised kompositsioonid, meetod antikehapreparaadi valmistamiseks ja meetod farmatseutilise kompositsiooni valmistamiseks